Tag: hepatocellular carcinoma

ABK Biomedical announces that its Eye90 microspheres device has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) | BioSpace

Medical Devices December 4, 2023

HALIFAX, NS, Dec. 5, 2023 /PRNewswire/ - ABK Biomedical, Inc., an innovative, medical device company dedicated to the research, development, and commercialization of advanced...

NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger | BioSpace

Medical Devices November 9, 2023

Pipeline Moves: Advancement prospects plunge for Bristol-Myers’ oncology drug after trial termination

Clinical Trials September 4, 2023

Evaluation of drug-induced liver toxicity of trovafloxacin and levofloxacin in a human microphysiological liver model – Scientific Reports

Biotechnology August 15, 2023

TriSalus merges with MedTech Acquisition to bolster cash reserves

Medical DevicesAugust 11, 2023

Drug delivery technology company TriSalus Life Sciences has merged with blank check company MedTech Acquisition Corporation (MedTech)...

Targeted shock-and-kill HIV-1 gene therapy approach combining CRISPR activation, suicide gene tBid and retargeted adenovirus delivery – Gene Therapy

BiotechnologyAugust 8, 2023

Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, et al. Presence of an inducible HIV-1 latent reservoir during highly active...

9 Notable AI Companies in Clinical Research to Watch in 2023

BiotechnologyJuly 25, 2023

The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% for drug candidates moving...

Hepatitis B: are we edging closer to a cure?

BiotechnologyJuly 3, 2023

A viral infection that affects the liver and can cause both acute and chronic disease, hepatitis B affects around 296 million people worldwide, and,...

FDA Approves Roctavian (valoctocogene roxaparvovec-rvox) Gene Therapy for Adults with Severe Hemophilia A

Clinical TrialsJune 29, 2023

FDA Approves Roctavian (valoctocogene roxaparvovec-rvox) Gene Therapy for Adults with Severe Hemophilia ASAN RAFAEL, Calif., June 29, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:...

Recent progress in the effect of magnetic iron oxide nanoparticles on cells and extracellular vesicles – Cell Death Discovery

Stem CellJune 27, 2023

Mahmoudi M, Hosseinkhani H, Hosseinkhani M, Boutry S, Simchi A, Journeay WS, et al. Magnetic resonance imaging tracking of stem cells in vivo using...

ABK Biomedical Announces FDA IDE Approval for a Multi-Center Pivotal Study of Eye90 microspheres in Hepatocellular Carcinoma | BioSpace

Medical DevicesMay 29, 2023

HALIFAX, NS, May 30, 2023 /PRNewswire/ - ABK Biomedical, Inc., an innovative, medical device company dedicated to the research, development, and commercialization of advanced...

Non-invasive activation of intratumoural gene editing for improved adoptive T-cell therapy in solid tumours – Nature Nanotechnology

Nano TechnologyMay 14, 2023

Hou, A. J., Chen, L. C. & Chen, Y. Y. Navigating CAR-T cells through the solid-tumor microenvironment. Nat. Rev. Drug Discov. 20, 531–550 (2021).Article ...

Latest Intelligence

Generative Data Intelligence